GBT Financial Facts
Earnings per share - basic: 0.13Earnings per share - diluted: 0.12
See Full Income Statement
Income tax payable: 3.03M
Other assets: 85.96K
See Full Balance Sheet
Global Blood Therapeutics (GBT) Earnings
|
Expand Research on GBT
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -1.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/3/22 | Q322 | N/A | -$1.12 | N/A | N/A | $75.79M | N/A | N/A | N/A | ||
| 8/8/22 | Q222 | -$1.12 | -$1.18 | +$0.06 | $47.56M | $64.39M | N/A |  | | Details | |
| 8/8/22 | Q222 | -$1.12 | -$1.18 | +$0.06 | $47.56M | $64.39M | N/A | | | Details | |
| 5/4/22 |  |
Q122 | -$1.26 | -$1.30 | +$0.04 | $55.16M | $56.14M | N/A | | | Details |
| 2/23/22 | |
Q421 | -$1.36 | -$1.13 | -$0.23 | $56.1M | $55.44M | N/A | | | Details |
11/4/21  |
|
Q321 | N/A | -$1.11 | N/A | N/A | $53.7M | N/A | N/A | N/A | |
| 8/3/21 | Q221 | -$1.12 | -$1.19 | +$0.07 | $47.6M | $43.84M | N/A | | | Details | |
| 5/5/21 |
|
Q121 | N/A | -$1.01 | N/A | N/A | $43M | N/A | N/A | N/A |
